Vitamin D Mood Randomized Trial: What the Evidence Says

Quick Answer

Vitamin D Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Additionally, the economic consequences are significant, resulting from decreased occupational productivity, increased absenteeism, and presenteeism. [Zainab Amani (2026); evidence level 1]
• Although the causes of PMS are not entirely clear, it is associated with an atypical sensitivity to regular cyclical hormonal shifts. [Zainab Amani (2026); evidence level 1]
• These manifestations not only affect daily functioning and productivity but also contribute to long-term health consequences, including reduced social engagement, impaired occupational performance and increased healthcare utilization. [Ray Prama (2026); evidence level 4]
• Although these symptoms are often attributed solely to hormonal shifts, emerging evidence suggests that nutritional deficiencies may play a significant and potentially modifiable role in the pathophysiology of perimenopausal fatigue and mood disorders. [Ray Prama (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin d mood randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zainab Amani (2026). Efficacy of Vitamin D Supplementation to Alleviate Premenstrual Syndrome Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. DOI: 10.3390/jcm15124828. PMCID: PMC13301900. PMID: 42355996. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13301900/
• Ray Prama (2026). Effect of vitamin D supplementation on fatigue and mood among perimenopausal women. DOI: 10.6026/973206300221638. PMCID: PMC13177140. PMID: 42145430. License: https://creativecommons.org/licenses/by/3.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC13177140/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.